Literature DB >> 30194082

Indirect Down-regulation of Tumor-suppressive let-7 Family MicroRNAs by LMO1 in Neuroblastoma.

Norihisa Saeki1, Akira Saito2, Yuki Sugaya2, Mitsuhiro Amemiya2, Hiroki Sasaki3.   

Abstract

BACKGROUND/AIM: Overall survival for the high-risk group of neuroblastoma (NB) patients still remains at 40-50%, necessitating the establishment of a curable treatment. LIM domain only 1 (LMO1) gene encoding a transcriptional regulator is an NB-susceptibility gene with a tumor-promoting activity. Previously we conducted chromatin immunoprecipitation and DNA sequencing analyses on NB cell lines and identified 3 protein-coding genes regulated by LMO1. In this study, we extended our analyses to capture microRNA genes directly or indirectly regulated by LMO1.
MATERIALS AND METHODS: Using microarrays, we conducted a comparative gene expression analysis on an NB cell line SK-N-SH; between the cells with and without LMO1 suppression.
RESULTS: Overall, 18 microRNAs were identified to be indirectly down-regulated by LMO1 including 7 microRNAs of the let-7 family, whose cell proliferation inhibitory activity was observed.
CONCLUSION: Target genes of the LMO1-regulated microRNAs and their relevant pathways may be a potential therapeutic target. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  LMO1; Neuroblastoma; let-7; microRNA; pediatric cancer

Mesh:

Substances:

Year:  2018        PMID: 30194082      PMCID: PMC6199578          DOI: 10.21873/cgp.20100

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  35 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  Cisplatin regulates SH-SY5Y cell growth through downregulation of BDNF via miR-16.

Authors:  Yun-Xiao Sun; Jian Yang; Ping-Yu Wang; You-Jie Li; Shu-Yang Xie; Ruo-Peng Sun
Journal:  Oncol Rep       Date:  2013-09-10       Impact factor: 3.906

3.  Identification and characterization of a novel integrin-linked kinase inhibitor.

Authors:  Su-Lin Lee; En-Chi Hsu; Chih-Chien Chou; Hsiao-Ching Chuang; Li-Yuan Bai; Samuel K Kulp; Ching-Shih Chen
Journal:  J Med Chem       Date:  2011-08-24       Impact factor: 7.446

Review 4.  Integrin-linked kinase: a cancer therapeutic target unique among its ILK.

Authors:  Gregory Hannigan; Armelle A Troussard; Shoukat Dedhar
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

Review 5.  Recent advances in neuroblastoma.

Authors:  John M Maris
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

6.  MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.

Authors:  B Zheng; L Liang; S Huang; R Zha; L Liu; D Jia; Q Tian; Q Wang; C Wang; Z Long; Y Zhou; X Cao; C Du; Y Shi; X He
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

7.  The Rsu-1-PINCH1-ILK complex is regulated by Ras activation in tumor cells.

Authors:  Gerard W Dougherty; Cynthia Jose; Mario Gimona; Mary Lou Cutler
Journal:  Eur J Cell Biol       Date:  2008-04-23       Impact factor: 4.492

8.  A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment.

Authors:  Agnieszka Rybak; Heiko Fuchs; Lena Smirnova; Christine Brandt; Elena E Pohl; Robert Nitsch; F Gregory Wulczyn
Journal:  Nat Cell Biol       Date:  2008-07-06       Impact factor: 28.824

9.  MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.

Authors:  Amanda Tivnan; Lorraine Tracey; Patrick G Buckley; Leah C Alcock; Andrew M Davidoff; Raymond L Stallings
Journal:  BMC Cancer       Date:  2011-01-25       Impact factor: 4.430

10.  APP intracellular domain acts as a transcriptional regulator of miR-663 suppressing neuronal differentiation.

Authors:  R Shu; W Wong; Q H Ma; Z Z Yang; H Zhu; F J Liu; P Wang; J Ma; S Yan; J M Polo; C C A Bernard; L W Stanton; G S Dawe; Z C Xiao
Journal:  Cell Death Dis       Date:  2015-02-19       Impact factor: 8.469

View more
  5 in total

Review 1.  Emerging therapeutic targets for neuroblastoma.

Authors:  Natarajan Aravindan; Terence Herman; Sheeja Aravindan
Journal:  Expert Opin Ther Targets       Date:  2020-10-06       Impact factor: 6.902

Review 2.  Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma.

Authors:  Omidvar Rezaei; Kasra Honarmand Tamizkar; Mohammadreza Hajiesmaeili; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

3.  Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry.

Authors:  Meiping Li; Lei Bao; Bo Lu; Wenshun Ge; Lifang Ren
Journal:  Diagn Pathol       Date:  2022-10-13       Impact factor: 3.196

Review 4.  Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma.

Authors:  Lisa Linck-Paulus; Claus Hellerbrand; Anja K Bosserhoff; Peter Dietrich
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

5.  MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution.

Authors:  Natarajan Aravindan; Karthikeyan Subramanian; Dinesh Babu Somasundaram; Terence S Herman; Sheeja Aravindan
Journal:  Cancer Drug Resist       Date:  2019-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.